Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
N.N. Petrov National Medical Research Center of Oncology
European Organisation for Research and Treatment of Cancer - EORTC
Sofwave Medical LTD
Goldman, Butterwick, Fitzpatrick and Groff
Goldman, Butterwick, Fitzpatrick and Groff
National Institutes of Health Clinical Center (CC)
Marmara University
Oncurious NV
C. R. Bard
University of California, San Francisco
National Institutes of Health Clinical Center (CC)
C. R. Bard
Neotropix